georgie18
Member Level
Re: None
Thursday, September 19, 2024 8:44:21 AM
Post#
395
of 396
XCUR...$5.81...🥳
georgie18
Member Level
Re: georgie18 post# 657765
Wednesday, September 18, 2024 4:57:06 PM
Post#
658327
of 658357
XCUR...$6.75...🥳Off my $2.11 Alert...
georgie18
Member Level
Re: georgie18 post# 657756
Monday, September 16, 2024 8:29:02 AM
Post#
657765
of 658325
XCUR...$2.61s clearing here...🥳...
georgie18
Member Level
Re: None
Monday, September 16, 2024 6:52:13 AM
Post#
364
of 371
XCUR...$2.50...Getting early morning volume...🥳
georgie18
Member Level
Re: georgie18 post# 656181
Friday, September 13, 2024 6:05:31 PM
Post#
657724
of 657755
XCUR...$2.82...🥳...
georgie18
Member Level
Re: georgie18 post# 356
Wednesday, August 28, 2024 11:40:53 AM
Post#
357
of 362
XCUR...$2.41s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 355
Wednesday, August 28, 2024 11:35:48 AM
Post#
356
of 356
XCUR...$2.29s clearing here...🥳off my $2.11 Alert...🥳
georgie18
Member Level
Re: georgie18 post# 652495
Wednesday, August 28, 2024 11:23:14 AM
Post#
655523
of 655531
XCUR...$2.11... Post Split...CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, “the Company”) today announced that it will effect a 1-for-5 reverse stock split of its outstanding shares of common stock (the “Reverse Stock Split”). The Company expects that the Reverse Stock Split will become effective at 5:00 pm on Tuesday, August 27, 2024, and its common stock will begin trading on a split-adjusted basis at the open of trading on Wednesday, August 28, 2024 under the new CUSIP number 30205M 309. Exicure’s common stock will continue to trade on the NASDAQ Capital Market under the symbol “XCUR”. The Reverse Stock Split is an effort to regain compliance with Nasdaq’s listing rules.
The Reverse Stock Split was approved by the Company’s stockholders at its Special Meeting of Stockholders held on August 20, 2024, to be effected by the Company’s Board of Directors within approved parameters. The Company’s Board of Directors approved the Reverse Stock Split at a ratio of 1-for-5 on August 20, 2024.
Recent XCUR News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:25:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 09:25:41 PM
- Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant • GlobeNewswire Inc. • 02/05/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:29:08 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 01/21/2026 06:21:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/21/2026 05:46:19 PM
- Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings • GlobeNewswire Inc. • 01/21/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2026 07:09:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 01:42:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2025 01:51:19 AM
- Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting • GlobeNewswire Inc. • 12/08/2025 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2025 04:50:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2025 09:52:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 09:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:18:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2025 09:07:04 PM
- Exicure, Inc. Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/07/2025 09:00:00 PM
- New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting • GlobeNewswire Inc. • 11/03/2025 02:00:00 PM
- Exicure Highlights Recent Achievements and Near-term Strategic Priorities • GlobeNewswire Inc. • 10/06/2025 11:00:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/23/2025 08:07:41 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
